Genotypic characterisation of vancomycin-resistant Enterococcus faecium isolates from haemato-oncological patients at Olomouc University Hospital, Czech Republic

Clinical Microbiology and Infection

Volumn 12, Issue 4, 2006, Pages 353-360

  Kolar, M ^a   Pantucek, R ^b   Vagnerova, I ^a   Kesselova, M ^a   Sauer, P ^a   Matouskova, I ^a   Doskar, J ^b   Koukalova, D ^a   Hejnar, P ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Czech Republic; Enterococcus faecium; Molecular epidemiology; Pulsed field gel electrophoresis; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; NITROFURANTOIN; RESTRICTION ENDONUCLEASE; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CANCER PATIENT; CZECH REPUBLIC; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENOTYPE; HEMATOLOGIC MALIGNANCY; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; UNIVERSITY HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 33644784844     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01365.x     Document Type: Article

References (46)

1. Bow EJ. Infection risk and cancer chemotherapy: The impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies. J Antimicrob Chemother 1998; 41 (suppl D): 1-5.
2. Oppenheim BA. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 1998; 41 (suppl D): 7-11.
3. Rolston KVI, Raad I, Whimbey E, Bodey GP. The changing spectrum of bacterial infections in febrile neutropenic patients. In: Klastersky JA, ed. Febrile neutropenia. Berlin: Springer-Verlag, 1997; 53-56.
4. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New Engl J Med 1988; 319: 157-161.
5. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; i: 57-58.
6. Speller DCE, Lynn WA, Rogers TR. Glycopeptide resistance in gram-positive bacteria. Clin Microbiol Infect 1995; 1: 54-59.
7. Weber DJ, Rutala WA. Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997; 18: 306-309.
8. Heath CH, Blackmore TK, Gordon DL. Emerging resistance in Enterococcus sp. Med J Aust 1996; 164: 116-120.
9. Kolar M, Vagnerova I, Latal T et al. The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use. Microbiologica 2002; 25: 205-212.
10. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by conventional test scheme. J Clin Microbiol 1989; 27: 731-734.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 12th informational supplement. Document M100-S12. Wayne, PA: NCCLS, 2002.
12. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24-27.
13. Kolar M, Pantucek R, Bardon J et al. Occurrence of antibiotic-resistant bacterial strains isolated in poultry. Vet Med Czech 2002; 47: 52-59.
14. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
15. Nei M, Li WH. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci USA 1979; 76: 5269-5273.
16. Descheemaeker PR, Chapelle S, Devriese LA, Butaye P, Vandamme P, Goossens H. Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origin. Antimicrob Agents Chemother 1999; 43: 2032-2037.
17. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn 1546, a Tn 3 -related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175: 117-127.
18. Murray BE. Vancomycin-resistant enterococci. Am J Med 1997; 101: 284-293.
19. Murray BE. Diversity among multidrug-resistant enterococci. Emerg Infect Dis 1998; 4: 37-47.
20. Padiglione AA, Wolfe R, Grabsch EA et al. Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother 2003; 47: 2492-2498.
21. Goossens H, Jabes D, Rossi R, Lammens C, Privitera G, Courvalin P. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J Antimicrob Chemother 2003; 51 (suppl 3): 5-12.
22. Kuriyama T, Williams DW, Patel M et al. Molecular characterization of clinical and environmental isolates of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from a teaching hospital in Wales. J Med Microbiol 2003; 52: 821-827.
23. Campanile F, Bartoloni A, Bartalesi F et al. Molecular alterations of VanA element in vancomycin-resistant enterococci isolated during a survey of colonized patients in an Italian intensive care unit. Microb Drug Resist 2003; 9: 191-199.
24. Bonora MG, Ligozzi M, De Fatima M et al. Vancomycin-resistant Enterococcus faecium isolates causing hospital outbreaks in northern Italy belong to the multilocus sequence typing C1 lineage. Microb Drug Resist 2004; 10: 114-123.
25. Stampone L, Del Grosso M, Boccia D, Pantosti A. Clonal spread of a vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting isolates in Italy. J Clin Microbiol 2005; 43: 1575-1580.
26. Novais C, Sousa JC, Coque TM et al. Molecular characterization of glycopeptide-resistant Enterococcus faecium isolates from Portuguese hospitals. Antimicrob Agents Chemother 2005; 49: 3073-3079.
27. Bopp LH, Schoonmaker DJ, Baltch AL, Smith RP, Ritz WJ. Molecular epidemiology of vancomycin-resistant enterococci from 6 hospitals in New York State. Am J Infect Control 1999; 27: 411-417.
28. Morrison D, Woodford N, Barrett SP, Sisson P, Cookson BD. DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J Clin Microbiol 1999; 37: 1084 -1091.
29. Werner G, Willems RJ, Hildebrandt B, Klare I, Witte W. Influence of transferable genetic determinants on the outcome of typing methods commonly used for Enterococcus faecium. J Clin Microbiol 2003; 41: 1499-1506.
30. Antonishyn NA, McDonald RR, Chan EL et al. Evaluation of fluorescence-based amplified fragment length polymorphism analysis for molecular typing in hospital epidemiology: Comparison with pulsed-field gel electrophoresis for typing strains of vancomycin-resistant Enterococcus faecium. J Clin Microbiol 2000; 38: 4058-4065.
31. Homan WL, Tribe D, Poznanski S et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002; 40: 1963-1971.
32. Jureen R, Harthug S, Sørnes S, Digranes A, Willems RJ, Langeland N. Comparative analysis of amplified fragment length polymorphism and pulsed field gel electrophoresis in a hospital outbreak and subsequent endemicity of ampicillin-resistant Enterococcus faecium. FEMS Immunol Med Microbiol 2004; 40: 33-39.
33. Vancanneyt M, Lombardi A, Andrighetto C et al. Intraspecies genomic groups in Enterococcus faecium and their correlation with origin and pathogenicity. Appl Environ Microbiol 2002; 68: 1381-1391.
34. Chadwick PR, Oppenheim BA, Fox A, Woodford N, Morgenstern GR, Scarffe JH. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J Hosp Infect 1996; 34: 171-182.
35. Scagnelli M, Pellizer G, de Lalla F et al. Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary-care hospital in Northern Italy. Eur J Clin Microbiol Infect Dis 2001; 20: 609-616.
36. Timmers GJ, Van der Zwet WC, Simoons-Smit IM et al. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: Risk factor assessment and successful control of the epidemic. Br J Haematol 2002; 116: 826-833.
37. Willems RJ, Top J, van Santen M et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11: 821-828.
38. Kawalec M, Gniadkowski M, Hryniewicz W. Outbreak of vancomycin-resistant enterococci in a hospital in Gdańsk, Poland, due to horizontal transfer of different Tn 1546 -like transposon variants and clonal spread of several strains. J Clin Microbiol 2000; 38: 3317-3322.
39. Noble MA, Isaac-Renton JL, Bryce EA et al. The toilet as a transmission vector of vancomycin-resistant enterococci. J Hosp Infect 1998; 40: 237-241.
40. Van den Braak N, Ott A, van Belkum A et al. Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands. Infect Control Hosp Epidemiol 2000; 21: 520-524.
41. Sample ML, Gravel D, Oxley C, Toye B, Garber G, Ramotar K. An outbreak of vancomycin-resistant enterococci in a hematology-oncology unit: control by patient cohorting and terminal cleaning of the environment. Infect Control Hosp Epidemiol 2002; 23: 468-470.
42. Suntharam N, Lankford MG, Trick WE, Peterson LR, Noskin GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002; 43: 183-188.
43. Oh HS, Kim EC, Oh MD, Choe KW. Outbreak of vancomycin resistant Enterococcus in a hematology/oncology unit in a Korean university hospital, and risk factors related to patients, staff, hospital care and facilities. Scand J Infect Dis 2004; 36: 790-794.
44. Kolar M, Cekanova L, Vagnerova I et al. Molecular-biological analysis of vancomycin-resistant enterococci isolated from a community in the Czech Republic. Biomed Papers 2004; 148: 167-169.
45. Bates J. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. J Hosp Infect 1997; 37: 89-101.
46. Kolar M, Bardon J, Vagnerova I et al. Occurrence of vancomycin-resistant enterococci in hens in the central region of Moravia. Vet Med Czech 2000; 45: 93-97.